Here are relevant reports on : robotic-cell-market
-
Minimally Invasive Surgical Instruments Market by Product (Handheld, Inflation Devices, Surgical Scopes), Type of Surgery (Cardiothoracic, Gastrointestinal, Bariatric, Orthopedic, Urological), Technology (Non-robotic, Robotic) - Global Forecast to 2029
The global minimally invasive surgical instruments market, valued at US$29.9 billion in 2023, stood at US$31.7 billion in 2024 and is projected to advance at a resilient CAGR of 9.5% from 2024 to 2029, culminating in a forecasted valuation of US$49.9 billion by the end of the period. The growth of this market is primarily fueled by the rising prevalence of surgical procedures globally, the advantages of minimally invasive surgery over traditional open techniques, and the increasing use of advanced robotics in ambulatory surgical centers.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Dispensing Systems Market by Technology Type (Robotic Dispensing, Semi-Robotic Dispensing, and Manual Dispensing), Application (Automotive, Electronics, Chemicals), and Geography - Global Forecast to 2020
Dispensing systems are material dispensing equipment with applications in a wide range of industries, such as chemicals, healthcare & pharmaceutical, industry & manufacturing, food & beverages, electronics, automotive, and construction, among others. The global dispensing systems market, in terms of value, is projected to reach USD 40.5 Billion by 2020 from USD 31.5 Billion in 2015, at a CAGR of 5.1% from 2015 to 2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
Cell Isolation Market/ Cell Separation Market by Product [Consumables (Media, Beads), Instrument (Centrifuges, Filtration)], Cell Type (Stem Cell), Source, Technique, Application (IVD, Research, CGT), End User, Competition, Region - Global Forecast to 2031
The global cell isolation market is projected to reach USD 7.97 billion by 2031, growing at a CAGR of 12.7% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Stem Cell Manufacturing Market by Product (Consumables, Instruments, Stem Cell Lines), Application (Research, Clinical, Cell Tissue & Banking), End User, Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2028
The global stem cell manufacturing market, valued at US$12.0 billion in 2022, stood at US$12.7 billion in 2023 and is projected to advance at a resilient CAGR of 11.3% from 2023 to 2028, culminating in a forecasted valuation of US$21.8 billion by the end of the period. The major factors driving the growth of this market are technological advancements in stem cell manufacturing and the increasing prevalence of genetic disorders, both of which are expected to propel market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Stem Cell Therapy Market by Cell Source (Adipose Tissue, Bone Marrow, Placenta, Umbilical Cord, iPSC), Type (Autologus Stem Cell), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Cardiovascular, Neurological), End User - Global Forecast to 2035
The global stem cell therapy market is projected to reach USD 3.65 billion by 2035, growing at a CAGR of 25.3% during the forecast period (2026–2035). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Cell Viability Assays Market by Product (MTT Assay, XTT Assay, Calcein, Resazurin, Flow Cytometry, Spectrophotometer), Cell Type (Human, Animal, Microbial), Application (Basic Research, Stem Cell, Discovery & Development) - Global Forecast to 2023
The global cell viability assays market is projected to reach USD 4.16 billion by 2023, growing at a CAGR of 8.4%. The prominent players in the cell viability assays market are Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Merck (Germany), GE Healthcare (US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), G-Biosciences (US), Creative Bioarray (US), Danaher Corporation (US), and Becton, Dickinson and Company (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
The global cell expansion market, valued at US$12.7 billion in 2023, stood at US$14.3 billion in 2024 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Cell Counting Market by Product (Instruments (Spectrophotometer, Flow Cytometer, Hematology Analyzers, Cell Counters), Consumables (Media, Reagents, Assays, Microplate)), Application, End User (Pharma & Biotech) - Global Forecast to 2029
The global Cell Counting Market, valued at US$10.82 billion in 2023, grew to US$11.12 billion in 2024 and is projected to reach US$11.83 billion in 2025. The market is expected to advance at a robust CAGR of 7.7% from 2024 to 2029, reaching an estimated US$16.14 billion by 2029. Increasing awareness and adoption of automated and fluorescence-based cell counters, along with declining costs, are driving broader market penetration across research laboratories, clinical diagnostics, and biopharmaceutical applications.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
In Vitro Toxicology Testing Market by Product (Equipment, Reagents, Kits, Software), Toxicity Endpoints & Type, Technology (Cell Culture, HTS), Method (Cell-based, Computational), Service (Type, Method), Region, Competition - Global Forecast to 2031
The global in vitro toxicology testing market is projected to reach USD 20.97 billion by 2031, growing at a CAGR of 10.6% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Cell Harvesting Market by Type (Manual, Automated), Application (Biopharmaceutical, Stem Cell Research), End User (Biotechnology, Biopharmaceutical Companies, Research Institute), and Region (North America, Europe, APAC, Row) - Global Forecasts to 2023
The global cell harvesting market is expected to reach USD 324.5 Million by 2023, at a CAGR of 8.7%. Some of the major players operating in the cell harvesting market are PerkinElmer (US), Brandel (US), TOMTEC (US), Cox Scientific (UK), Connectorate (Switzerland), Scinomix (US), ADSTEC (Japan), and Terumo BCT (a part of Terumo Corporation) (Japan).
- Published: March 2018
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50